Total Funding: 100000000.0
Headquarters: Cambridge, Massachusetts, United States
Funding Status: Early Stage Venture
Last Funding Type: Series A
Last Funding Date: 2022-10-14
Investors Number: 6.0
Founded Date: 2021-01-01
Industry: Early Drug Development